The sustained influence of metformin therapy on circulating GLP-1 levels in individuals with and without type 2 diabetes

<strong>Aims:</strong> Small, short studies suggest metformin influences the glucagon-like peptide (GLP)-1 axis in individuals with and without type 2 diabetes (T2DM). In the Carotid Atherosclerosis: Metformin for insulin ResistAnce (CAMERA) trial (NCT00723307) we investigated whether th...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Preiss, D, Dawed, A, Welsh, P, Heggie, A, Jones, A, Dekker, J, Koivula, R, Hansen, T, DIRECT consortium, Stewart, C, Holman, R, Franks, P, Walker, M, Pearson, E, Sattar, N
Natura:	Journal article
Pubblicazione:	Wiley 2016

The sustained influence of metformin therapy on circulating GLP-1 levels in individuals with and without type 2 diabetes

Documenti analoghi